Table 4.

Estimated hazard ratios of event incidence in the treatment group compared to control groups

	vs. Control group 1 Screened candidate		vs. Control group 2 Beneficiary within inclusion criteria
Diabetes-related complications (all)	1.14	(0.67–1.93)	0.60*	(0.36–1.00)
Ischemic heart disease	1.38	(0.48–3.93)	1.67	(0.56–5.02)
Stroke	0.43	(0.05–3.67)	0.21	(0.03–1.59)
Retinopathy requiring surgery	1.25	(0.53–2.97)	0.65	(0.27–1.59)
Neuropathy	2.71	(0.82–8.92)	1.49	(0.51–4.37)
End-stage renal disease requiring dialysis	0.63	(0.07–5.52)	0.15	(0.02–1.16)
Intensive care use	1.09	(0.48–2.45)	0.63	(0.28–1.43)
Emergency care use	0.79	(0.49–1.29)	0.59*	(0.37–0.94)
All-cause hospitalization	0.90	(0.69–1.18)	0.82	(0.63–1.06)
Dependency in activities of daily living	0.78	(0.22–2.80)	0.69	(0.20–2.38)
All-cause mortality	1.50	(0.51–4.41)	0.72	(0.27–1.90)

^*P < 0.05

Adjusted for age, sex, diabetes medication, and Charlson comorbidity index